GERRESHEIMER AG (GXI.DE) Stock Fundamental Analysis
FRA:GXI - Deutsche Boerse Ag - DE000A0LD6E6 - Common Stock - Currency: EUR
We assign a fundamental rating of 4 out of 10 to GXI. GXI was compared to 15 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of GXI while its profitability can be described as average. GXI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year GXI was profitable.
GXI had a positive operating cash flow in the past year.
Each year in the past 5 years GXI has been profitable.
GXI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
GXI has a Return On Assets (2.88%) which is comparable to the rest of the industry.
GXI has a better Return On Equity (7.26%) than 70.59% of its industry peers.
With a Return On Invested Capital value of 5.18%, GXI perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for GXI is in line with the industry average of 6.82%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.88% | ||
| ROE | 7.26% | ||
| ROIC | 5.18% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
GXI has a Profit Margin of 5.39%. This is comparable to the rest of the industry: GXI outperforms 58.82% of its industry peers.
GXI's Profit Margin has been stable in the last couple of years.
GXI has a worse Operating Margin (9.70%) than 76.47% of its industry peers.
In the last couple of years the Operating Margin of GXI has grown nicely.
GXI's Gross Margin of 29.85% is on the low side compared to the rest of the industry. GXI is outperformed by 70.59% of its industry peers.
GXI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.7% | ||
| PM (TTM) | 5.39% | ||
| GM | 29.85% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GXI is destroying value.
GXI has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for GXI has been increased compared to 5 years ago.
The debt/assets ratio for GXI is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.70, we must say that GXI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of GXI (1.70) is worse than 82.35% of its industry peers.
GXI has a Debt/Equity ratio of 0.61. This is a neutral value indicating GXI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.61, GXI perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.7 |
ROIC/WACC0.74
WACC7.02%
2.3 Liquidity
A Current Ratio of 1.01 indicates that GXI should not have too much problems paying its short term obligations.
With a Current ratio value of 1.01, GXI is not doing good in the industry: 88.24% of the companies in the same industry are doing better.
GXI has a Quick Ratio of 1.01. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
GXI's Quick ratio of 0.65 is on the low side compared to the rest of the industry. GXI is outperformed by 88.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.65 |
3. Growth
3.1 Past
The earnings per share for GXI have decreased by -7.90% in the last year.
The Earnings Per Share has been growing slightly by 4.31% on average over the past years.
Looking at the last year, GXI shows a small growth in Revenue. The Revenue has grown by 2.28% in the last year.
GXI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.90% yearly.
EPS 1Y (TTM)-7.9%
EPS 3Y5.98%
EPS 5Y4.31%
EPS Q2Q%-11%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%4.35%
3.2 Future
The Earnings Per Share is expected to grow by 19.54% on average over the next years. This is quite good.
Based on estimates for the next years, GXI will show a quite strong growth in Revenue. The Revenue will grow by 9.64% on average per year.
EPS Next Y20.03%
EPS Next 2Y21.05%
EPS Next 3Y21.63%
EPS Next 5Y19.54%
Revenue Next Year21.07%
Revenue Next 2Y14.49%
Revenue Next 3Y12.94%
Revenue Next 5Y9.64%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 25.20, GXI can be considered very expensive at the moment.
76.47% of the companies in the same industry are more expensive than GXI, based on the Price/Earnings ratio.
GXI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.35.
The Price/Forward Earnings ratio is 14.48, which indicates a correct valuation of GXI.
GXI's Price/Forward Earnings ratio is rather cheap when compared to the industry. GXI is cheaper than 94.12% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, GXI is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.2 | ||
| Fwd PE | 14.48 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GXI is valued cheaper than 82.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.84 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
GXI's earnings are expected to grow with 21.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.26
PEG (5Y)5.85
EPS Next 2Y21.05%
EPS Next 3Y21.63%
5. Dividend
5.1 Amount
GXI has a Yearly Dividend Yield of 1.56%. Purely for dividend investing, there may be better candidates out there.
GXI's Dividend Yield is rather good when compared to the industry average which is at 0.79. GXI pays more dividend than 94.12% of the companies in the same industry.
GXI's Dividend Yield is slightly below the S&P500 average, which is at 2.33.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.56% |
5.2 History
The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years5
5.3 Sustainability
GXI pays out 41.41% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of GXI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP41.41%
EPS Next 2Y21.05%
EPS Next 3Y21.63%
FRA:GXI (3/7/2025, 7:00:00 PM)
80.15
+0.05 (+0.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners96.73%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap2.77B
Analysts84.17
Price Target103.85 (29.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.56% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP41.41%
Div Incr Years0
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.23%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)-1.21%
Revenue beat(4)1
Avg Revenue beat(4)-0.77%
Min Revenue beat(4)-1.25%
Max Revenue beat(4)0.22%
Revenue beat(8)3
Avg Revenue beat(8)-0.74%
Revenue beat(12)6
Avg Revenue beat(12)0.08%
Revenue beat(16)6
Avg Revenue beat(16)-0.11%
PT rev (1m)-5.94%
PT rev (3m)-8.6%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.23%
EPS NY rev (3m)-4.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.91%
Revenue NY rev (3m)5.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.2 | ||
| Fwd PE | 14.48 | ||
| P/S | 1.36 | ||
| P/FCF | N/A | ||
| P/OCF | 11.52 | ||
| P/B | 1.83 | ||
| P/tB | 10.24 | ||
| EV/EBITDA | 9.84 |
EPS(TTM)3.18
EY3.97%
EPS(NY)5.54
Fwd EY6.91%
FCF(TTM)-3.75
FCFYN/A
OCF(TTM)6.96
OCFY8.68%
SpS58.94
BVpS43.76
TBVpS7.83
PEG (NY)1.26
PEG (5Y)5.85
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.88% | ||
| ROE | 7.26% | ||
| ROCE | 6.99% | ||
| ROIC | 5.18% | ||
| ROICexc | 5.62% | ||
| ROICexgc | 10.73% | ||
| OM | 9.7% | ||
| PM (TTM) | 5.39% | ||
| GM | 29.85% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexcg growth 3Y-17.1%
ROICexcg growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.31 | ||
| Cap/Depr | 186.29% | ||
| Cap/Sales | 18.17% | ||
| Interest Coverage | 3.27 | ||
| Cash Conversion | 60.69% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.65 | ||
| Altman-Z | 1.7 |
F-Score4
WACC7.02%
ROIC/WACC0.74
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.9%
EPS 3Y5.98%
EPS 5Y4.31%
EPS Q2Q%-11%
EPS Next Y20.03%
EPS Next 2Y21.05%
EPS Next 3Y21.63%
EPS Next 5Y19.54%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%4.35%
Revenue Next Year21.07%
Revenue Next 2Y14.49%
Revenue Next 3Y12.94%
Revenue Next 5Y9.64%
EBIT growth 1Y-7.43%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year126.42%
EBIT Next 3Y41.97%
EBIT Next 5Y32.68%
FCF growth 1Y-284.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.35%
OCF growth 3Y4.26%
OCF growth 5Y4.49%